Skip to content

Aging of the Vascular Wall

Aging of the Vascular Wall

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07122427
Acronym
VITAL
Enrollment
30
Registered
2025-08-14
Start date
2025-07-17
Completion date
2026-12-31
Last updated
2025-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging Disorder, Vascular Risk

Keywords

Cardiovascular diseases, Aging, Eendothelial dysfunction

Brief summary

Demographic aging is predicted to be one of the most significant social changes of the 21st century. Aging is a slow, multifactorial process that progressively impacts the integrity of cells, tissues, and organs. This decline in function increases the risk of numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases (CVD). CVD, the leading global cause of death, becomes more prevalent with age. Aging contributes to endothelial dysfunction, vessel stiffness, thickening, and impaired platelet function. These changes disrupt hemostatic processes and increase the risk of cardiovascular complications. Despite preventive strategies CVD remain a major public health challenge. Cellular aging, or senescence, affects all cell types, particularly endothelial cells and platelets. However, little research has compared the aging rates of different blood vessel types, such as arteries and veins. Given their distinct compositions and developmental origins, it is likely that their aging processes differ at molecular, cellular, and physiological levels.

Interventions

PROCEDUREGraft collection

Sampling of superior venous and arterial grafts (internal mammary artery, great saphenous vein) after coronary artery bypass surgery.

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major patients requiring coronary artery bypass grafting (CABG).

Exclusion criteria

* Hypertension, diabetes, systemic inflammatory disease.

Design outcomes

Primary

MeasureTime frameDescription
Biomarkers of ageingDay 1Detection of innovative biomarkers of ageing by microscope analysis.

Countries

France

Contacts

Primary ContactAnne-Claire DUCHEZ, PhD
anne-claire.duchez@efs.sante.fr(0)477421423
Backup ContactSalvatore CAMPISI, MD
salvatore.campisi@chu-st-etienne.fr(0)477829058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026